FOI Foccini International

Foccini International Inc. ("Foccini" or the "Company")(TSX VENTURE:FOI)
announces that it has signed a term sheet with the University of Calgary (the
"University") and Arch Biotech Inc. ("Arch"), providing for the basic terms of a
future equity and overhead agreement between the parties (the "Term Sheet").


The execution of a definitive agreement is conditional on Foccini's exercise of
its option to purchase all of the issued and outstanding common shares of Arch
(the "Option"). The terms of the Option are more particularly described in
Foccini's press release dated May 6, 2009.


Pursuant to the Term Sheet, the University will exchange its revenue sharing
rights in the intellectual property produced by the Arch research programs at
the University of Calgary in exchange for an equity stake in Arch. The
University and Arch will also enter into an overhead agreement to allow Arch
scientists to continue using University labs and infrastructure to advance the
Arch research programs.


In the event Foccini exercises its Option, Foccini has agreed to issue 1,576,000
common shares to the University in return for the University's equity stake in
Arch. These shares will be issued at a deemed price of $0.20 per share for a
total value of $315,200.


If Foccini exercises its Option such transaction will constitute a change of
business pursuant to the policies of the TSX Venture Exchange (the "Exchange"),
and at such time Foccini will file a change of business application with the
Exchange and issue a comprehensive press release. Completion of the transactions
described in this press release are subject to compliance with all necessary
regulatory and other approvals and certain other terms and conditions,
including, among other things, the approval of the Exchange.


About Arch Biotech

Arch is a private Ontario based company that has been established to acquire
biomedical technology with commercial potential and oversee its development
until it can be sold or licensed to suitable marketing partners.


Completion of the transactions described in this press release is subject to a
number of conditions, including Exchange acceptance and shareholder approval.
The transactions described herein cannot close until the required shareholder
approval is obtained. There can be no assurance that the transactions described
herein will be completed as proposed or at all.


Investors are cautioned that, except as disclosed in the Management Information
Circular to be prepared in connection with the transaction, any information
released or received with respect to the transaction may not be accurate or
complete and should not be relied upon. Trading in the securities of Foccini
International Inc. should be considered highly speculative.


The TSX Venture Exchange has in no way passed upon the merits of the proposed
transaction and has neither approved nor disapproved the contents of this press
release.


Foccini currently has 27,321,179 common shares issued and outstanding.

For more information on Foccini, please consult the other public documents filed
on SEDAR at www.sedar.com.


Forward-Looking Statements

All statements, other than statements of historical fact, in this news release
are forward looking statements that involve various risks and uncertainties,
including, without limitation, statements regarding the future plans and
objectives of the Company. There can be no assurance that such statements will
prove to be accurate. Actual results and future events could differ materially
from those anticipated in such statements. These and all subsequent written and
oral forward-looking statements are based on the estimates and opinions of
management on the dates they are made and are expressly qualified in their
entirety by this notice. The Company assumes no obligation to update
forward-looking statements should circumstances or management's estimates or
opinions change.

Foccini International (TSXV:FOI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

Foccini International (TSXV:FOI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024